Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Land LH, Dalton SO, Jensen MB, Ewertz M. Influence of comorbidity on the effect of adjuvant treatment and age in patients with early-stage breast cancer. Br J Cancer. 2012;107:1901–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V, Cruz-Flores S, et al. Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association. Circulation 2018;137:e30–e66.

Article  PubMed  PubMed Central  Google Scholar 

Ministry of Health. Annual update of key results 2018/19: New Zealand Health Survey [Internet]. 2019 [cited 2024 Apr 7]. Available from: https://www.health.govt.nz/publication/annual-update-key-results-2018-19-new-zealand-health-survey.

Ford ES, Li C, Zhao G, Pearson WS, Tsai J, Greenlund KJ. Trends in low-risk lifestyle factors among adults in the United States: findings from the Behavioral Risk Factor Surveillance System 1996–2007. Prev Med. 2010;51:403–7.

Article  PubMed  Google Scholar 

Feingold KR. Triglyceride lowering drugs. In: Feingold K, Anawalt B, Blackman M, editors. South Dartmouth, MA: Endotext; 2021.

Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267–78.

Article  CAS  PubMed  Google Scholar 

Ehmsen S, Pedersen MH, Wang G, Terp MG, Arslanagic A, Hood BL, et al. Increased cholesterol biosynthesis is a key characteristic of breast cancer stem cells influencing patient outcome. Cell Rep. 2019;27:3927–38.

Article  CAS  PubMed  Google Scholar 

Borgquist S, Djerbi S, Ponten F, Anagnostaki L, Goldman M, Gaber A, et al. HMG-CoA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors. Int J Cancer. 2008;123:1146–53.

Article  CAS  PubMed  Google Scholar 

Beckwitt CH, Brufsky A, Oltvai ZN, Wells A. Statin drugs to reduce breast cancer recurrence and mortality. Breast Cancer Res. 2018;20:144.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blanco-Colio LM, Tunon J, Martin-Ventura JL, Egido J. Anti-inflammatory and immunomodulatory effects of statins. Kidney Int. 2003;63:12–23.

Article  CAS  PubMed  Google Scholar 

Bellosta S, Ferri N, Bernini F, Paoletti R, Corsini A. Non-lipid-related effects of statins. Ann Med. 2000;32:164–76.

Article  CAS  PubMed  Google Scholar 

Beckwitt CH, Clark AM, Ma B, Whaley D, Oltvai ZN, Wells A. Statins attenuate outgrowth of breast cancer metastases. Br J Cancer. 2018;119:1094–105.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ghosh-Choudhury N, Mandal CC, Ghosh-Choudhury N, Choudhury GG. Simvastatin induces derepression of PTEN expression via NFκB to inhibit breast cancer cell growth. Cell Signal. 2010;22:749–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Campbell MJ, Esserman LJ, Zhou Y, Shoemaker M, Lobo M, Borman E, et al. Breast cancer growth prevention by statins. Cancer Res. 2006;66:8707–14.

Article  CAS  PubMed  Google Scholar 

Zhong S, Zhang X, Chen L, Ma T, Tang J, Zhao J. Statin use and mortality in cancer patients: systematic review and meta-analysis of observational studies. Cancer Treat Rev. 2015;41:554–67.

Article  CAS  PubMed  Google Scholar 

Mansourian M, Haghjooy-Javanmard S, Eshraghi A, Vaseghi G, Hayatshahi A, Thomas J. Statins use and risk of breast cancer recurrence and death: a systematic review and meta-analysis of observational studies. J Pharm Pharm Sci. 2016;19:72–81.

Article  PubMed  Google Scholar 

Manthravadi S, Shrestha A, Madhusudhana S. Impact of statin use on cancer recurrence and mortality in breast cancer: a systematic review and meta-analysis. Int J Cancer. 2016;139:1281–8.

Article  CAS  PubMed  Google Scholar 

Liu B, Yi Z, Guan X, Zeng YX, Ma F. The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysis. Breast Cancer Res Treat. 2017;164:1–11.

Article  CAS  PubMed  Google Scholar 

Lv H, Shi D, Fei M, Chen Y, Xie F, Wang Z, et al. Association between statin use and prognosis of breast cancer: a meta-analysis of cohort studies. Front Oncol. 2020;10:556243.

Article  PubMed  PubMed Central  Google Scholar 

Xu WH, Zhou YH. The relationship between post-diagnostic statin usage and breast cancer prognosis varies by hormone receptor phenotype: a systemic review and meta-analysis. Arch Gynecol Obstet. 2021;304:1315–21.

Article  PubMed  Google Scholar 

Zhao G, Ji Y, Ye Q, Ye X, Wo G, Chen X, et al. Effect of statins use on risk and prognosis of breast cancer: a meta-analysis. Anticancer Drugs. 2022;33:e507–e18.

Article  CAS  PubMed  Google Scholar 

Jaiswal V, Agrawal V, Ang SP, Saleeb M, Ishak A, Hameed M, et al. Post-diagnostic statin use and its association with cancer recurrence and mortality in breast cancer patients: a systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2023;9:731–40

Jia X, Lu Y, Xu Z, Mu Q. Impact of statin use on breast cancer recurrence and mortality before and after diagnosis: a systematic review and meta-analysis. Front Oncol. 2023;13:1256747.

Löfling LL, Stoer NC, Andreassen BK, Ursin G, Botteri E. Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study. Breast Cancer Res. 2023;25:101.

Article  PubMed  PubMed Central  Google Scholar 

Murto MO, Simolin N, Arponen O, Siltari A, Artama M, Visvanathan K, et al. Statin use, cholesterol level, and mortality among females with breast cancer. JAMA Netw Open. 2023;6:e2343861–e.

Article  PubMed  PubMed Central  Google Scholar 

Dumas E, Grandal Rejo B, Gougis P, Houzard S, Abécassis J, Jochum F, et al. Concomitant medication, comorbidity and survival in patients with breast cancer. Nat Commun. 2024;15:2966.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giorello MB, Marks MP, Osinalde TM, del Rosario Padin M, Wernicke A, Calvo JC, et al. Post-surgery statin use contributes to favorable outcomes in patients with early breast cancer. Cancer Epidemiol. 2024;90:102573.

Article  PubMed  Google Scholar 

Guo H, Malone KE, Heckbert SR, Li CI. Statin use and risks of breast cancer recurrence and mortality. cancer. 2024;130:3106–14.

Suissa S. Immortal time bias in pharmacoepidemiology. Am J Epidemiol. 2008;167:492–9.

Article  PubMed  Google Scholar 

Inasu M, Feldt M, Jernstrom H, Borgquist S, Harborg S. Statin use and patterns of breast cancer recurrence in the Malmö diet and cancer study. Breast 2022;61:123–8.

Article  PubMed  PubMed Central  Google Scholar 

Warita K, Warita T, Beckwitt CH, Schurdak ME, Vazquez A, Wells A, et al. Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion. Sci Rep. 2014;4:7593.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koohestanimobarhan S, Salami S, Imeni V, Mohammadi Z, Bayat O. Lipophilic statins antagonistically alter the major epithelial-to-mesenchymal transition signaling pathways in breast cancer stem-like cells via inhibition of the mevalonate pathway. J Cell Biochem. 2019;120:2515–31.

Article  CAS  PubMed  Google Scholar 

Schneeweiss S, Patrick AR, Sturmer T, Brookhart MA, Avorn J, Maclure M, et al. Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med. Care. 2007;45:S131–42.

Article  PubMed  PubMed Central  Google Scholar